| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.460 | 65.141 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.460 | 68.218 |
| Total Expenses - EUR | 643 | 389 | 305 | 284 | 278 | 273 | 287 | 320 | 7.066 | 116.965 |
| Gross Profit/Loss - EUR | -643 | -389 | -305 | -284 | -278 | -273 | -287 | -320 | -4.606 | -48.747 |
| Net Profit/Loss - EUR | -643 | -389 | -305 | -284 | -278 | -273 | -287 | -320 | -4.606 | -48.747 |
| Employees | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 |
Check the financial reports for the company - Euromedlab Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 45.570 | 45.010 | 44.233 | 43.422 | 42.581 | 41.773 | 40.847 | 64.106 | 78.403 | 85.053 |
| Current Assets | 14.813 | 14.588 | 14.327 | 14.064 | 13.792 | 13.530 | 13.234 | 16.149 | 43.761 | 44.670 |
| Inventories | 11.090 | 10.977 | 10.792 | 10.594 | 10.388 | 10.191 | 9.965 | 9.996 | 27.878 | 5.860 |
| Receivables | 3.589 | 3.553 | 3.493 | 3.429 | 3.362 | 3.298 | 3.229 | 6.084 | 12.381 | 34.209 |
| Cash | 133 | 58 | 43 | 42 | 41 | 41 | 40 | 69 | 3.502 | 4.601 |
| Shareholders Funds | 30.776 | 30.074 | 29.261 | 28.440 | 27.611 | 26.815 | 25.933 | 25.694 | 21.009 | -27.855 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 29.606 | 29.525 | 29.300 | 29.046 | 28.762 | 28.489 | 28.148 | 54.562 | 101.155 | 157.578 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4755 - 4755" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Euromedlab Srl